These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9632348)

  • 1. Spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists.
    Yang L; Guo L; Pasternak A; Mosley R; Rohrer S; Birzin E; Foor F; Cheng K; Schaeffer J; Patchett AA
    J Med Chem; 1998 Jun; 41(13):2175-9. PubMed ID: 9632348
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent 3-spiropiperidine growth hormone secretagogues.
    Yang L; Morriello G; Prendergast K; Cheng K; Jacks T; Chan WW; Schleim KD; Smith RG; Patchett AA
    Bioorg Med Chem Lett; 1998 Jan; 8(1):107-12. PubMed ID: 9925440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.
    Yang L; Berk SC; Rohrer SP; Mosley RT; Guo L; Underwood DJ; Arison BH; Birzin ET; Hayes EC; Mitra SW; Parmar RM; Cheng K; Wu TJ; Butler BS; Foor F; Pasternak A; Pan Y; Silva M; Freidinger RM; Smith RG; Chapman K; Schaeffer JM; Patchett AA
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10836-41. PubMed ID: 9724791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles.
    van Niel MB; Collins I; Beer MS; Broughton HB; Cheng SK; Goodacre SC; Heald A; Locker KL; MacLeod AM; Morrison D; Moyes CR; O'Connor D; Pike A; Rowley M; Russell MG; Sohal B; Stanton JA; Thomas S; Verrier H; Watt AP; Castro JL
    J Med Chem; 1999 Jun; 42(12):2087-104. PubMed ID: 10377215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
    Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
    Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity.
    Rajeswaran WG; Hocart SJ; Murphy WA; Taylor JE; Coy DH
    J Med Chem; 2001 Apr; 44(9):1416-21. PubMed ID: 11311064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor.
    Zaveri NT; Jiang F; Olsen CM; Deschamps JR; Parrish D; Polgar W; Toll L
    J Med Chem; 2004 Jun; 47(12):2973-6. PubMed ID: 15163178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs.
    Liu Q; Cescato R; Dewi DA; Rivier J; Reubi JC; Schonbrunn A
    Mol Pharmacol; 2005 Jul; 68(1):90-101. PubMed ID: 15855408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells.
    Parmar RM; Chan WW; Dashkevicz M; Hayes EC; Rohrer SP; Smith RG; Schaeffer JM; Blake AD
    Biochem Biophys Res Commun; 1999 Sep; 263(2):276-80. PubMed ID: 10491284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.
    Sharif N; Gendron L; Wowchuk J; Sarret P; Mazella J; Beaudet A; Stroh T
    Endocrinology; 2007 May; 148(5):2095-105. PubMed ID: 17272399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.
    Rohrer SP; Birzin ET; Mosley RT; Berk SC; Hutchins SM; Shen DM; Xiong Y; Hayes EC; Parmar RM; Foor F; Mitra SW; Degrado SJ; Shu M; Klopp JM; Cai SJ; Blake A; Chan WW; Pasternak A; Yang L; Patchett AA; Smith RG; Chapman KT; Schaeffer JM
    Science; 1998 Oct; 282(5389):737-40. PubMed ID: 9784130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of subtype selective somatostatin receptor agonists.
    Rohrer SP; Schaeffer JM
    J Physiol Paris; 2000; 94(3-4):211-5. PubMed ID: 11087999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
    Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
    J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(4-Piperidinyl)indoles and 3-(4-piperidinyl)pyrrolo-[2,3-b]pyridines as ligands for the ORL-1 receptor.
    Bignan GC; Battista K; Connolly PJ; Orsini MJ; Liu J; Middleton SA; Reitz AB
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3524-8. PubMed ID: 16632355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists.
    Hayashi R; Ohmori E; Moriwaki M; Kumagai H; Isogaya M
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3921-3. PubMed ID: 26238322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rodent selectivity of piperidine-4-yl-1H-indoles, a series of CC chemokine receptor-3 (CCR3) antagonists: insights from a receptor model.
    Kriegl JM; Martyres D; Grundl MA; Anderskewitz R; Dollinger H; Rast G; Schmid B; Seither P; Tautermann CS
    Bioorg Med Chem Lett; 2015 Jan; 25(2):229-35. PubMed ID: 25497216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly potent cyclic disulfide antagonists of somatostatin.
    Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
    J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors.
    Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Costa L; Ciranna L; Prezzavento O; Arena E; Ronsisvalle S; Bruno G; Chimirri A
    J Med Chem; 2011 Dec; 54(24):8702-6. PubMed ID: 22050212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.